^
    BIOMARKER:
    BRAF V600E
    i
    Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
    Entrez ID:
    673
    Related biomarkers:
    Mutation
    CNA
    Fusion
    Others
    BRAF V600E
    Melanoma
    Immunotherapy
    Resistant
    :
    C3
    SID 2021 - 3wk
    BRAF V600E
    CRC
    cetuximab + binimetinib + encorafenib
    Sensitive
    :
    A1
    BRAF V600E
    CRC
    cetuximab + encorafenib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    dabrafenib
    Sensitive
    :
    A1
    BRAF V600E
    NSCLC
    trametinib + dabrafenib
    Sensitive
    :
    A1
    BRAF V600E
    Thyroid Gland Anaplastic Carcinoma
    trametinib + dabrafenib
    Sensitive
    :
    A1
    BRAF V600E
    Thyroid Gland Anaplastic Carcinoma
    dabrafenib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    trametinib + dabrafenib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    vemurafenib + cobimetinib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    vemurafenib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    trametinib
    Sensitive
    :
    A1
    BRAF V600E
    Melanoma
    binimetinib + encorafenib
    Sensitive
    :
    A1
    BRAF V600E
    NSCLC
    vemurafenib
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    trametinib + dabrafenib
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    vemurafenib + cobimetinib
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    vemurafenib
    Sensitive
    :
    A2
    BRAF V600E
    Cutaneous Melanoma
    trametinib + dabrafenib
    Sensitive
    :
    A2
    BRAF V600E
    Biliary Tract Cancer
    trametinib + dabrafenib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    trametinib + dabrafenib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    vemurafenib + cobimetinib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    cobimetinib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    vemurafenib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    trametinib
    Sensitive
    :
    A2
    BRAF V600E
    Astrocytoma
    dabrafenib
    Sensitive
    :
    A2
    BRAF V600E
    Ganglioglioma
    cobimetinib
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES